Doug Williamson

Doug Williamson is a highly experienced medical executive with a distinguished background in leading research and development in the pharmaceutical industry. As Chief Medical Officer at QurAlis and Avadel Pharmaceuticals plc, Doug has demonstrated expertise in guiding medical strategy and innovation. Their role as Executive Vice President and Head of R&D at Acadia Pharmaceuticals Inc. showcases a strong track record in advancing drug development. Additionally, Doug serves as an Independent Director at Bright Minds Biosciences and has held significant positions at Lundbeck as Senior Vice President, overseeing U.S. R&D and serving as Deputy Global Chief Medical Officer.